China Medical Technologies Inc. (CMED) reported that its second-quarter net loss was RMB47.1 million or US$6.9 million, compared to net income of RMB 110.85 million in the year ago quarter. Loss from continuing operations per ADS for the quarter was RMB 1.78 or US$0.26, compared to profit of RMB 2.20 per ADS last year.
Non-GAAP income from continuing operations decreased by 82.7% year-over-year to RMB17.7 million or US$2.6 million. Non-GAAP earnings from continuing operations per ADS, decreased by 82.6% year-over-year to RMB 0.67 or US$0.10.
Revenues for the quarter were RMB 166.1 million or US$24.3 million, down from RMB 193.97 million in the year go quarter.
For the third-quarter, the company expects revenues to be in the range of US$24.9 million - US$26.4 million. The company estimates the target non-GAAP income from continuing operations to be not less than US$5.6 million.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.